CVA Family Office’s ArcBest ARCB Stock Holding History

CVA Family Office’s Portfolio ARCB Stock Details ARCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12	Closed	-$847	–	1298
2025 Q1	$847	Buy	+12	New	+$1.04K	﹤0.01%	1145

Other funds holding ARCB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

CVA Family Office's ARCB Position: Q2 2025 in Review

CVA Family Office sold out of ArcBest (ARCB) in Q2 2025, closing a stake of 12 shares — an estimated $847 sold.

CVA Family Office first reported a position in ARCB in Q1 2025 and held it in 1 quarter. The position peaked at $847 in Q1 2025. 275 funds tracked by Wall St. Rank hold ARCB as of Q2 2025.

CVA Family Office reported no remaining ArcBest position as of Q2 2025 after selling out during the quarter.
CVA Family Office sold 12 ArcBest shares in Q2 2025, an estimated $847.
CVA Family Office first reported a position in ArcBest in Q1 2025 and held it in 1 quarter.
CVA Family Office's ArcBest position peaked at $847 in Q1 2025.
275 funds tracked by Wall St. Rank held ArcBest as of Q2 2025.

Based on CVA Family Office's 13F filing for Q2 2025, filed 31 Jul 2025.